Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;54(3):e14114.
doi: 10.1111/eci.14114. Epub 2023 Oct 24.

Comparison between interventional versus medical therapy in patients with rheumatic mitral valve stenosis in Tanzania

Reuben K Mutagaywa  1   2   3   4 , Engerasiya Kifai  2 , Mercy Elinisa  2 , Henry Mayala  2 , Peter Kisenge  2 , Tulizo Shemu  2 , Evarist Nyawawa  2 , Peter P Kunambi  1 , Respicious Boniface  3 , Aileen Barongo  5 , Gideon Kwesigabo  1 , Appolinary Kamuhabwa  1 , Steven Chamuleau  6 , Maarten J Cramer  4 , Pilly Chillo  1   2
Affiliations

Comparison between interventional versus medical therapy in patients with rheumatic mitral valve stenosis in Tanzania

Reuben K Mutagaywa et al. Eur J Clin Invest. 2024 Mar.

Abstract

Background: Rheumatic heart disease remains the most common cardiovascular disease in children and young adults. The outcome of interventional versus medical therapy on the long term is not fully elucidated yet. This study provides contemporary data on the clinical profile, treatment and follow up of patients with rheumatic mitral stenosis (MS) in Tanzania.

Methods: Patients' medical information, investigations and treatment data were recorded in this prospective cohort study. They were followed up for 6-24 months to determine the long-term outcome. Interventional therapy was defined as a combination of surgery and percutaneous balloon mitral valvuloplasty. Kaplan-Meier curves and Cox proportional hazards model were used in analyses. p-Value < 0.05 was considered statistically significant.

Results: We enrolled 290 consecutive patients. Interventions were done in half of the patients. Median follow up was 23.5 months. Mortality was higher in the medical than interventional treatment (10.4% vs. 4%, log-rank p = 0.001). Median age was 36 years, females (68.3%) and low income (55.5%). Multivalvular disease was found in 116 (40%) patients, atrial fibrillation (31.4%), stroke/transient ischaemic attack (18.9%) and heart failure class III-IV (44.1%). Median (IQR) duration of disease was 3 (4) years, secondary prophylaxis (27.7%) and oral anticoagulants use (62.3%). In multivariable analysis, the risk of death among patients on medical was 3.07 times higher than those on interventional treatment (crude HR 3.07, 95% CI 1.43-6.56, p = 0.004), 2.44 times higher among patients with arrhythmias versus without arrhythmias (crude HR 2.44, 95% CI 1.19-4.49, p = 0.015) and 2.13 times higher among patients with multivalvular than single valve disease (crude HR 2.13, 95% CI 1.09-4.16, p = 0.026).

Conclusions: Intervention is carrying low mortality compared to medical treatment. Arrhythmias and multivalvular disease are associated with a high mortality. Rheumatic MS is more prevalent in young people, females and individuals with low income. There is a late hospital presentation and a low use of both secondary prophylactic antibiotics and anticoagulants.

Keywords: medical treatment; mortality, Tanzania; predictors; rheumatic mitral stenosis; surgery.

PubMed Disclaimer

References

REFERENCES

    1. Zühlke L, Karthikeyan G, Engel ME, et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: two-year follow-up of the global rheumatic heart disease registry (the REMEDY study). Circulation. 2016;134(19):1456-1466.
    1. Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and National Burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377(8):713-722.
    1. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM. Position statement of the world heart federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10(5):284-292.
    1. Kazahura PT, Mushi TL, Pallangyo P, et al. Prevalence and risk factors for subclinical rheumatic heart disease among primary school children in Dar es Salaam, Tanzania: a community based cross-sectional study. BMC Cardiovasc Disord. 2021;21(1):1-14.
    1. Kingue S, Ba SA, Balde D, et al. The VALVAFRIC study: a registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016;109(5):321-329.

LinkOut - more resources